FineHeart is pioneering advancements in the treatment of advanced heart failure through its innovative medical device, the FlowMaker®. This device represents a significant breakthrough as the first fully implantable cardiac output accelerator, designed to restore the heart's normal contraction and improve patient outcomes. The FlowMaker® operates as a hybrid between a pacemaker and a cardiac assist device, providing physiological support that is synchronized with the heart's natural flow and contractility. Its unique design eliminates common complications associated with traditional left ventricular assist devices (LVADs), such as the need for a percutaneous driveline and aortic bypass cannula, thereby enhancing patient safety and quality of life.

The FlowMaker® is implanted via beating heart surgery and features an intelligent controller that can be adjusted to meet individual patient needs. It utilizes an epicardial lead to synchronize the pump's pulsatility and is powered through a wireless transcutaneous energy transfer system. FineHeart has successfully completed the manufacturing process for clinical trials, collaborating with certified production partners, and is in the process of engaging with regulatory bodies like the FDA to secure breakthrough technology designation. The company’s commitment to innovation is further underscored by its recent achievements in clinical trials, confirming the device's proof of concept and marking a significant milestone in the treatment of heart failure.

France

FineHeartis a French medical device company focused on creatingtechnologies in the cardiovascular field. The FineHeartinvention, anI.C.O.M.S. (Implantable Cardiac Output Management System), is wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility.

FineHeart

Company Details